Pancreatic neuroendocrine tumors (PanNENs) are rare sporadic cancers or develop as part
of hereditary syndromes. PanNENs can be both functioning and non-functioning based on …

Pancreatic cancer (PC), particularly its most common form, pancreatic ductal
adenocarcinoma (PDAC), is relatively rare but highly lethal. Knowledge about PC risk …

Abstract Neuroendocrine tumors (NETs)[carcinoids, pancreatic neuroendocrine tumors
(pNETs)] are becoming an increasing clinical problem because not only are they increasing …

Background Poorly differentiated neuroendocrine carcinomas (NECs) are rare and
aggressive tumors. Their molecular pathogenesis is still largely unknown, and consequently …

Neuroendocrine neoplasms (NENs) are a relatively rare group of heterogeneous tumours
originating from neuroendocrine cells found throughout the body. Pancreatic NENs …

Some biomarkers for functioning and non-functioning neuroendocrine neoplasms (NENs)
are currently available. Despite their application in clinical practice, results should be …

Pancreatic neuroendocrine neoplasms (pNENs) are rare cancers with broad challenges for
their management. The main clinical obstacles are the high rate of patients diagnosed at …

D-type cyclins encode G1/S cell cycle checkpoint proteins, which play a crucial role in
defining cell cycle exit and progression. Precise control of cell cycle exit is vital during …

We have previously shown that α-thalassemia mental retardation X-linked (ATRX) and
histone H3. 3 are key regulators of telomeric chromatin in mouse embryonic stem cells. The …

Pancreatic neuroendocrine neoplasms (PanNENs) are the neuroendocrine neoplasms with
greatest rate of increase in incidence. Approximately 10% of PanNENs arise as inherited …